Skip to main content
. 2022 Oct 17;30(2):267–276. doi: 10.1038/s41417-022-00541-7

Fig. 6. SNX1.3 inhibits RTK driven 2D cell migration.

Fig. 6

BT20 triple negative breast cancer cells were treated with either cSNX1.3, PTD4 control or vehicle (water) and either EGF-, Neuregulin-1 (NRG), Hepatic Growth Factor (HGF), or hyaluronic acid (HA)-induced migration on plastic was allowed for 12 h. Area migrated was measured with ImageJ.